Eleven Biotherapeutics Inc (NASDAQ:EBIO)

2.80
Delayed Data
As of 3:42pm ET
 -0.005 / -0.18%
Today’s Change
2.54
Today|||52-Week Range
13.78
-76.43%
Year-to-Date

Today’s Trading

Previous close2.81
Today’s open2.82
Day’s range2.65 - 2.85
Volume49,265
Average volume (3 months)514,935
Market cap$54.3M
Dividend yield--
Data as of 3:42pm ET, 07/28/2015

Growth & Valuation

Earnings growth (last year)-66.90%
Earnings growth (this year)+40.17%
Earnings growth (next 5 years)+30.00%
Revenue growth (last year)+68.14%
P/E ratioNM
Price/Sales77.56
Price/Book1.37

Competitors

 Today’s
change
Today’s
% change
EVARLombard Medical Inc+0.23+6.87%
CRBPCorbus Pharmaceutica...-0.08-3.90%
MEIPMEI Pharma Inc+0.03+1.94%
VICLVical Inc+0.03+4.59%
Data as of 3:54pm ET, 07/28/2015

Financials

Next reporting dateAugust 12, 2015
EPS forecast (this quarter)-$0.27
Annual revenue (last year)$2.2M
Annual profit (last year)-$34.2M
Net profit margin-1,522.78%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Abbie C. Celniker
Chief Financial &
Accounting Officer
John J. McCabe
Corporate headquarters
Cambridge, Massachusetts

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers